Jason L. Rowand

Endothelial cells in peripheral blood of healthy subjects and patients with metastatic carcinomas

Jason L. Rowand, Grace Martin, Gerald V. Doyle et al. · Cytometry Part A · 2007 · 124 citations

Medicine, Clinical Sciences, Oncology +13

Developability studies before initiation of process development

Xiaoyu Yang, Wei Xu, Svetlana Dukleska et al. · mAbs · 2013 · 118 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

Peter Sabbatini, Susan Korenchuk, Jason L. Rowand et al. · Molecular Cancer Therapeutics · 2009 · 98 citations · Full text

Medicine, Oncology, Pharmacology +13

Antitumor Activity of GSK1904529A, a Small-molecule Inhibitor of the Insulin-like Growth Factor-I Receptor Tyrosine Kinase

Peter Sabbatini, Jason L. Rowand, Arthur Groy et al. · Clinical Cancer Research · 2009 · 80 citations · Full text

Medicine, Oncology, Pharmacology +16

Optimization of 4,6-bis-anilino-1H-pyrrolo[2,3-d]pyrimidine IGF-1R tyrosine kinase inhibitors towards JNK selectivity

Stanley D. Chamberlain, Anikó M. Redman, Joseph W. Wilson et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 58 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +12